Broadening the spectrum of NTRK rearranged mesenchymal tumors and usefulness of pan-TRK immunohistochemistry

Industry Publications

|

December 9, 2022

Broadening the spectrum of NTRK rearranged mesenchymal tumors and usefulness of pan-TRK immunohistochemistry

Fusions involving NTRK1, NTRK2, and NTRK3 are oncogenic drivers occurring in a spectrum of mesenchymal neoplasms ranging from benign to highly malignant tumors.

Read full article

Click here to open the document

Click here to see the answer

Latest Publications

View All Publications

Members-Only

Extramedullary Involvement in T/Myeloid Mixed Phenotype Acute Leukemia With BCR::ABL1 Fusion in a Hispanic Female Patient: A Case Report

MPAL is rare (~2–5% of acute leukemias), with the T/Myeloid subtype especially challenging due to its mixed lineage and extramedullary presentation. The presence of BCR::ABL1 further complicates treatment strategies. This case underscores the power of combining histopathology, immunophenotyping, and molecular testing for accurate diagnosis and early targeted treatment.

A Huge Conjunctival Atypical Fibroxanthoma

A case of a Hispanic male whose conjunctival atypical fibroxanthoma (AFX) grew very large, with intraocular as well as extraocular muscle extensions, and was treated with exenteration.

Lupus Anticoagulants: Guidelines for testing and interpretation

Dr. Moraima Reyes Gil's presentation from our 2024 Annual Meeting.

Conference Presentations

|

April 10, 2025

Members-Only

Abnormal coagulation tests: Artifacts, Interferences or True coagulopathies

Dr. Moraima Reyes Gil's presentation from our 2024 Annual Meeting.

Conference Presentations

|

April 10, 2025

pracademyofpathology@gmail.com

Urb. Crown Hills 138 Ave. Winston Churchill, PMB 527, San Juan, PR 00926-6013